This insider cluster is routine and non-informative. The Bodenhoff sale is a standard cashless exercise pattern (exercise options, sell to cover cost/tax). No C-suite participation and trivial dollar amounts relative to market cap. No trading action warranted. Monitor for any future C-suite open-market sales exceeding 0.1% of market cap, which would carry more signal.
Price Chart
Executive Summary
Two Ascendis Pharma insiders sold a combined $873K in shares over a 7-day window, with the bulk ($811K) coming from SVP Mads Bodenhoff's open-market sale following a derivative exercise. Director Lars Holtug sold a small $62K stake. At a $17.7B market cap, the total sales represent ~0.005% of market cap — well below the 0.1% materiality threshold — making this a routine, non-informative cluster. The derivative exercise and same-day sale by Bodenhoff is a classic cashless exercise pattern, not a bearish signal. Historical calibration shows strong past long calls on ASND (100% win rate T+20), but this cluster lacks the dollar weight to be actionable.
Key Financial Metrics
Key Facts
- Two insiders sold shares totaling $873K (0.005% of $17.7B market cap)
- SVP Mads Bodenhoff exercised 3,000 options at $110, then sold the same shares at $270.19 for $811K — a routine cashless exercise
- Director Lars Holtug sold 236 shares for $62K — a trivial position reduction
- No C-suite executives (CEO/CFO) participated in the cluster
- The cluster is too small relative to market cap to carry informational content
Financial Impact
Total insider sales of $873K represent 0.005% of $17.7B market cap — immaterial
Risk Factors
- Insider sales could accelerate if stock continues to rise, but current pattern is normal liquidity-driven activity
- No bearish signal from this cluster — risk of misinterpreting routine option exercises as informed selling
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-ASND-1789027639214 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 9, 2026 23d ago | Insider Cluster | $260.81 $247.69 | ▼ −5.03% | ▼ −4.37% | $227.23 (−12.88%) |
Aug 31, 2026 4w ago | 6-K | $260.25 $260.81 | ▲ +0.22% | ▲ +0.13% | $227.23 (−12.69%) |
Aug 27, 2026 5w ago | ANALYST-UPGRADE | $249.36 $271.12 | ▲ +8.73% | ▲ +8.46% | $227.23 (−8.87%) |
Aug 19, 2026 6w ago | ANALYST-UPGRADE | $259.62 $250.25 | ▼ −3.61% | ▼ −3.22% | $227.23 (−12.48%) |
Aug 19, 2026 6w ago | Insider Buy | $259.62 $250.25 | ▼ −3.61% | ▼ −3.22% | $227.23 (−12.48%) |
Aug 13, 2026 7w ago | 6-K | $246.23 $254.81 | ▲ +3.48% | ▲ +5.45% | $227.23 (−7.72%) |
Aug 13, 2026 7w ago | Press Release | $246.23 $254.81 | ▲ +3.48% | ▲ +5.45% | $227.23 (−7.72%) |
Aug 6, 2026 8w ago | 6-K | $249.85 $246.23 | ▼ −1.45% | ▼ −2.66% | $227.23 (−9.05%) |
Aug 6, 2026 8w ago | Press Release | $249.85 $246.23 | ▼ −1.45% | ▼ −2.66% | $227.23 (−9.05%) |
Jul 15, 2026 11w ago | 6-K | $259.80 $252.66 | ▼ −2.75% | ▼ −1.08% | $227.23 (−12.54%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access